5 research outputs found
Phase I dose-escalation study of cabazitaxel administered in combination with cisplatin in patients with advanced solid tumors
No full textPhase I study of cabazitaxel plus cisplatin in patients with advanced solid tumors: study to evaluate the impact of cytochrome P450 3A inhibitors (aprepitant, ketoconazole) or inducers (rifampin) on the pharmacokinetics of cabazitaxel
No full text
